Ovagen (20 mg Vial)

Ovagen (20 mg Vial) is supplied as a lyophilized vial for laboratory research use. This page covers reconstitution volume, the resulting concentration, U-100 syringe equivalents and storage handling.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Ovagen (20 mg Vial)

Synonyms/Alias: Ovagen

Purity: Specification by inquiry

Custom Peptide Support

  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

Ovagen (20 mg Vial) is supplied as a lyophilized vial for laboratory research use. This page covers reconstitution volume, the resulting concentration, U-100 syringe equivalents and storage handling.

Quickstart

Reconstitute: Add 2.0 mL bacteriostatic water → 10 mg/mL (10,000 µg/mL) concentration.

Typical daily range: 10–150 µg once daily (gradual titration over 16 weeks).

Easy measuring: At 10 mg/mL, 1 unit = 0.01 mL = 100 µg on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Notes

Practical considerations for consistency and safety. Use new sterile insulin syringes (30-unit or 50-unit preferred for low-volume accuracy); dispose in a sharps container. Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation. Inject slowly; wait a few seconds before withdrawing the needle. Document daily dose and site rotation to maintain consistency. Label the vial with date/time of reconstitution, diluent volume, final concentration, and initials [4].

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Weeks 1–2
Daily Dose (µg): 10 µg (0.01 mg) | Units (per injection) (mL): 0.1 units (0.001 mL)
Weeks 3–4
Daily Dose (µg): 20 µg (0.02 mg) | Units (per injection) (mL): 0.2 units (0.002 mL)
Weeks 5–6
Daily Dose (µg): 50 µg (0.05 mg) | Units (per injection) (mL): 0.5 units (0.005 mL)
Weeks 7–8
Daily Dose (µg): 100 µg (0.1 mg) | Units (per injection) (mL): 1 unit (0.01 mL)
Weeks 9–16
Daily Dose (µg): 100–150 µg (0.1–0.15 mg) | Units (per injection) (mL): 1–1.5 units (0.01–0.015 mL)
Long-term Storage Conditions
Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (Ovagen, 20 mg each): 16 weeks: 1 vial (with excess remaining)

Insulin Syringes (U-100, 30-unit or 50-unit recommended): Per week: 7 syringes (1/day)

16 weeks: 112 syringes (recommend ~120 with extras)

Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution. 16 weeks (1 vial): 2 mL → 1 × 10 mL bottle

Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day)

16 weeks: 224 swabs → recommend 3 × 100-count boxes

Product Gallery

Quick Inquiry

Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsAppMia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China

Related Products

Related Services